Suchergebnisse - "Yamada, Suguru"

PubPharm (585)

21

ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9

enthalten in: Annals of surgical oncology | 2022

von Yamanaka, M. | Hayashi, M. | Sonohara, F. | +15

22

Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9

enthalten in: Annals of surgical oncology | 2022

von Yamanaka, M. | Hayashi, M. | Sonohara, F. | +15

23

Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9

enthalten in: Annals of surgical oncology | 2022

von Yamanaka, M. | Hayashi, M. | Sonohara, F. | +15

24

Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study Group

enthalten in: Journal of hepato-biliary-pancreatic sciences | 2022

von Satoi, S. | Takahara, N. | Fujii, T. | +17

25

Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01)

enthalten in: Annals of surgery | 2022

von Yamaguchi, J. | Yokoyama, Y. | Fujii, T. | +10

26

Clip-Guided Local Duodenectomy for Safe and Minimal Local Resection of Nonampullary Duodenal Neoplasms

enthalten in: ResearchSquare.com | 2022

von Miwa, T. | Yamada, S. | Shibuya, K. | +7

27

Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer : a study protocol for a double-blind randomized phase II study

enthalten in: Trials | 2022

von Hashimoto, D. | Satoi, S. | Ishikawa, H. | +10

28

Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study

enthalten in: Trials | 2022

von Hashimoto, D. | Satoi, S. | Ishikawa, H. | +10

29

Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study

enthalten in: Trials | 2022

von Hashimoto, D. | Satoi, S. | Ishikawa, H. | +10

30

Surgical results of non-ampullary duodenal cancer : a nationwide survey in Japan

enthalten in: Journal of gastroenterology | 2022

von Nakagawa, K. | Sho, M. | Okada, K. | +15